Scarica l'app Stockscreener
4.00
5.66%
-0.24
Dopo l'orario di chiusura:
4.01
0.010
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.24
Aprire:
$4.245
Volume 24 ore:
2.58M
Relative Volume:
0.66
Capitalizzazione di mercato:
$431.62M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-1.4545
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
+8.99%
1M Prestazione:
+23.08%
6M Prestazione:
-34.96%
1 anno Prestazione:
-77.85%
Intervallo 1D:
$3.985
$4.335
Intervallo di 1 settimana:
$3.39
$4.5093
Portata 52W:
$2.19
$18.89
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Nome
Rocket Pharmaceuticals Inc
Settore
Industria
Telefono
646-440-9100
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Confronta RCKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
4.00 | 460.75M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-30 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Downgrade | Goldman | Neutral → Sell |
| 2025-05-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Downgrade | Needham | Buy → Hold |
| 2025-05-27 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2024-12-30 | Iniziato | Wedbush | Outperform |
| 2024-12-18 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-04-02 | Iniziato | Goldman | Neutral |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Iniziato | Morgan Stanley | Overweight |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-01 | Iniziato | BTIG Research | Buy |
| 2022-07-08 | Iniziato | Raymond James | Outperform |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Iniziato | JP Morgan | Overweight |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2019-11-06 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-26 | Iniziato | Piper Jaffray | Overweight |
| 2019-04-23 | Iniziato | Robert W. Baird | Outperform |
| 2019-03-15 | Iniziato | BofA/Merrill | Buy |
| 2019-02-05 | Iniziato | Oppenheimer | Outperform |
| 2018-09-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
What’s next for Rocket Pharmaceuticals Inc. stock priceWeekly Gains Report & Fast Exit and Entry Trade Guides - newser.com
Chart based analysis of Rocket Pharmaceuticals Inc. trendsJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com
RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - Yahoo Finance
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reports2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
What dividend safety score for Rocket Pharmaceuticals Inc. stockDollar Strength & Real-Time Buy Signal Alerts - newser.com
Will a bounce in Rocket Pharmaceuticals Inc. offer an exit2025 Key Lessons & Low Risk High Win Rate Picks - newser.com
Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock - simplywall.st
Analyzing Rocket Pharmaceuticals Inc. Equity Warrant with risk reward ratio chartsJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
RCKT: Chardan Capital Maintains 'Buy' Rating with $11 PT | RCKT Stock News - GuruFocus
FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock - Benzinga
Rocket Pharmaceuticals Shares Surge after FDA Accepts Drug Application Resubmission - MarketScreener
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment o - PharmiWeb.com
Rocket Pharmaceuticals (RCKT) Resubmitted Gene Therapy Applicati - GuruFocus
Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ) - Seeking Alpha
Rocket Pharma Gets FDA Review Date for Severe Immune Disorder Drug Candidate - MarketScreener
FDA Accepts Rocket Pharmaceuticals' Resubmission for Kresladi Ge - GuruFocus
FDA Accepts Rocket Pharmaceuticals' BLA Resubmission for Rare Genetic Disorder Treatment - MarketScreener
Why Rocket Pharma Is Rising In Pre-market? - Nasdaq
Rocket Pharmaceuticals’ FDA Resubmission for KRESLADI™ Accepted - TipRanks
FDA accepts Rocket Pharmaceuticals’ gene therapy BLA for rare disease - Investing.com
FDA accepts Rocket Pharmaceuticals' resubmitted gene therapy application - StreetInsider
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Business Wire
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressuresMarket Performance Recap & Risk Controlled Stock Alerts - newser.com
Will Rocket Pharmaceuticals Inc. stock go up soonJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Lobbying Update: $30,000 of ROCKET PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Heatmap analysis for Rocket Pharmaceuticals Inc. Equity Warrant and competitors2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com
Why Rocket Pharmaceuticals Inc. stock is in analyst buy zoneMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Can a trend reversal in Rocket Pharmaceuticals Inc. Equity Warrant lead to recoveryDip Buying & Stock Portfolio Risk Management - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Rocket Pharmaceuticals Inc. Equity Warrant stock bottoming outQuarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Should you hold or exit Rocket Pharmaceuticals Inc. now2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
Published on: 2025-10-10 06:17:17 - newser.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Published on: 2025-10-10 04:39:16 - newser.com
Building trade automation scripts for Rocket Pharmaceuticals Inc. Equity Warrant2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc. Equity WarrantMarket Volume Report & High Win Rate Trade Alerts - newser.com
How sentiment analysis helps forecast Rocket Pharmaceuticals Inc. Equity WarrantPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock profit from fiscal stimulusEarnings Beat & Intraday High Probability Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Reach Out - ACCESS Newswire
How to manage a losing position in Rocket Pharmaceuticals Inc. Equity Warrant2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 05:44:17 - newser.com
Published on: 2025-10-09 03:18:17 - newser.com
Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Rocket Pharmaceuticals Inc Azioni (RCKT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bjork Elisabeth | Director |
Aug 27 '25 |
Buy |
3.41 |
10,000 |
34,100 |
40,000 |
| Militello John | See Remarks |
Aug 18 '25 |
Sale |
3.06 |
699 |
2,142 |
56,285 |
| Militello John | See Remarks |
Aug 19 '25 |
Sale |
3.00 |
361 |
1,082 |
55,924 |
| Schwartz Jonathan David | See Remarks |
Aug 18 '25 |
Sale |
3.06 |
1,680 |
5,149 |
222,414 |
| Schwartz Jonathan David | See Remarks |
Aug 19 '25 |
Sale |
3.00 |
805 |
2,412 |
221,609 |
| Wilson Martin | General Counsel |
Aug 18 '25 |
Sale |
3.06 |
1,004 |
3,077 |
136,050 |
| Wilson Martin | General Counsel |
Aug 19 '25 |
Sale |
3.00 |
588 |
1,762 |
135,462 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):